Bristol-Myers Squibb is on course to move its BCMA-targeting CAR-T therapy further up the treatment pathway in multiple myeloma, after reporting that it met its objectives in a phase 3 trial.

GT005 is a one-shot therapy which aims to treat GA by delivering the gene for complement factor I (CFI) to the eye using an adeno-associated virus (AAV) vector. CFI regulates the activity of the ...

Johnson & Johnson and Merck are laying off employees in China ... facility in Plainville provides viral vector services ranging from process development to commercial manufacturing. Charles River ...

ZILLOW GONE WILD: “A government contractor and lobbyist who served in President Donald Trump’s first administration bought Vice President JD Vance ’s Virginia home in an above-market deal, a sale his ...

LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...

Easter is on its way, but wedding season is right around the corner, and Betsey Johnson has spring special-occasion styling for both. The designer’s Friends & Family Sale is on, with 30% off ...

A fight is breaking out among House Republicans over whether to allow new parents in Congress to vote remotely — a politically explosive issue that is gaining traction in the chamber at a ...

WASHINGTON, March 25 (Reuters) - U.S. House Speaker Mike Johnson on Tuesday warned that Congress' authority over the federal judiciary includes the power to eliminate entire district courts, as ...